ONE-WAYOngoing theme · still written in the latest filings
Preparation for entry into the ophthalmic pharmaceutical business in China
An initiative to advance TLG-001 clinical trials in China and prepare for entry into the ophthalmic pharmaceutical business in the Chinese market, based on the Eye Valley site and contracts and licenses with Chinese companies.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.